AgeX Therapeutics, Inc. is a biotechnology company founded in 2017 by Dr. Michael D. West, a respected researcher in cellular aging, stem cell research, telomerase and cloning. West previously founded Geron Corporation and under his leadership the cell immortalizing gene telomerase was originally discovered. He also led the collaborative effort that resulted in the isolation of the first pluripotent stem cells. Michael West has also conducted important research to reverse cellular aging in human cells via nuclear transfer and cellular reprogramming. The company seeks to develop rejuvenation therapeutics that target the aging processes to extend healthy human lifespans.